C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01)
Patent
CA 2650448
Subject of invention allow to synthesize DNA and identification of germline BRCAl genetic abnormalities which are correlated with a significantly decreased clinical response to neoadjuvant chemotherapy based on taxane-derived cytostatics in breast cancer patients.
La présente invention concerne la synthèse de l'ADN et l'identification dans la lignée germinale d'anomalies génétiques du gène BRCAl corrélées à une diminution importante de la réponse clinique à une chimiothérapie préopératoire basée sur des cytostatiques dérivés de taxane chez des patientes ayant un cancer du sein.
Byrski Tomasz
Gronwald Jacek
Huzarski Tomasz
Lubinski Jan
Narod Steven
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Byrski Tomasz
Gronwald Jacek
Huzarski Tomasz
Lubinski Jan
LandOfFree
Fast assignment of adequate neoadjuvant chemotherapy for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fast assignment of adequate neoadjuvant chemotherapy for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fast assignment of adequate neoadjuvant chemotherapy for... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1745318